T follicular helper cells: linking cancer immunotherapy and immune-related adverse events (vol 9, e002588, 2021)

被引：0
|
作者：
Baumjohann, D.
Brossart, P.
机构：
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷 / 08期
关键词：
D O I：
10.1136/jitc-2021-002588corr1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Phenotypic insights into genetic risk factors for immune-related adverse events in cancer immunotherapy
    Ma, Haochuan
    Song, Dili
    Zhang, Haibo
    Li, Taidong
    Jin, Xing
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 74 (01)
  • [22] Safety of Immunotherapy Rechallenge After Immune-related Adverse Events in Patients With Advanced Cancer
    Kartolo, Adi
    Holstead, Ryan
    Khalid, Sidra
    Emack, Jeffrey
    Hopman, Wilma
    Baetz, Tara
    JOURNAL OF IMMUNOTHERAPY, 2021, 44 (01) : 41 - 48
  • [23] Association of antibiotic treatment with immune-related adverse events in patients with cancer receiving immunotherapy
    Jing, Ying
    Chen, Xue
    Li, Kunyan
    Liu, Yaoming
    Zhang, Zhao
    Chen, Yiqing
    Liu, Yuan
    Wang, Yushu
    Lin, Steven H.
    Diao, Lixia
    Wang, Jing
    Lou, Yanyan
    Johnson, Douglas B.
    Chen, Xiang
    Liu, Hong
    Han, Leng
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (01)
  • [24] Patterns of immune-related adverse events in early-phase cancer immunotherapy trials
    Fairfax, B. P.
    Schmid, V. C.
    Lamparter, D. F.
    Kam-Thong, T.
    Scepanovic, P.
    Duchateau-Nguyen, G.
    Roller, A.
    Mohindra, R.
    Karanikas, V.
    Heinzmann, D.
    Adams, C.
    Mycroft, S. L.
    Stadler, N.
    ANNALS OF ONCOLOGY, 2024, 35 : S278 - S278
  • [25] Placebo immune-related adverse events (irAEs): A neglected phenomenon in cancer immunotherapy trials
    Zhou, Yixin
    Yu, Hui
    Chen, Chen
    Li, Anlin
    Zhang, Xuanye
    Qiu, Huijuan
    Du, Wei
    Fu, Sha
    Zhang, Li
    Hong, Shaodong
    EUROPEAN JOURNAL OF CANCER, 2024, 208
  • [26] Immune-related adverse events (IrAEs) as a predictor of response to immunotherapy in patients with lung cancer
    Sanchez Becerra, M. V.
    Martinez-Cabanes, R.
    Gonzalez-Lopez, A.
    Zhan-Zhou, E.
    Sotelo, V.
    Esteban, M.
    Robles, T.
    Camara, J. C.
    Cardena, A.
    Hernando, S.
    Hurtado, A.
    Moreno, D.
    Olier, C.
    Mielgo Rubio, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) : S808 - S809
  • [27] Increased Frequency of Bone Marrow T Follicular Helper Cells in Patients with Immune-Related Pancytopenia
    Yu, Hong
    Zhang, Jiangbo
    Fu, Rong
    Liu, Hui
    Wang, Huaquan
    Ding, Kai
    Wang, Yihao
    Li, Lijuan
    Wang, Honglei
    Shao, Zonghong
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [28] EULAR recommendations for the diagnosis and the management of rheumatic immune-related adverse events due to cancer immunotherapy
    Kostine, M.
    Finckh, A.
    Bingham, C. O.
    Visser, K.
    Leipe, J.
    Schulze-Koops, H.
    Choy, E.
    Benesova, K.
    Radstake, T.
    Cope, A.
    Lambotte, O.
    Gottenberg, J-E.
    Allenbach, Y.
    Jamal, S.
    Marabelle, A.
    Larkin, J. M. G.
    Haanen, J. B. A. G.
    Calabrese, L.
    Mariette, X.
    Schaeverbeke, T.
    ANNALS OF ONCOLOGY, 2019, 30 : 528 - 528
  • [29] ASSOCIATIONS BETWEEN CARDIOVASCULAR DISEASES AND IMMUNE-RELATED ADVERSE EVENTS IN CANCER PATIENTS RECEIVING IMMUNOTHERAPY
    Oren, Ohad
    Oren, Michal
    Molina, Julian
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 3331 - 3331
  • [30] Tofacitinib for the treatment of immune-related adverse events in cancer immunotherapy: A multi-center study
    Liu, Q.
    Liu, M.
    Zou, Z.
    Lin, J.
    Wang, Y.
    Zhang, N.
    Zhao, L.
    Zhou, J.
    Zhou, H.
    Zhou, X.
    Jiao, X.
    Yu, Y.
    Liu, T.
    ANNALS OF ONCOLOGY, 2023, 34 : S1633 - S1633
12345